The Voltage Between Us

Nora Flynn had exactly seven minutes to save her company, a cold cup of coffee, and whatever remained of her dignity after tripping over the welcome mat on her way into the Caldwell Incubator's glass lobby. She had caught herself on the reception desk — barely — and now stood in the atrium of London's most prestigious startup accelerator with a raspberry-red flush climbing her freckled neck, her copper hair rioting around her shoulders despite the three bobby pins she'd stabbed into it that morning, and a pitch deck clutched to her chest like a shield. Five foot two in her best heels. Still the shortest person in the room by a significant margin. She did not let herself look around. She did not need to see the sleek, angular people in their sleek, angular suits to know she stuck out. She already knew. She had always known. But knowing and caring were two different things, and Nora Flynn had spent twenty-eight years perfecting the art of not caring — or at least performing not caring with convincing precision. She found a seat at the long communal table in the pre-session holding room, set down her laptop, and opened her deck. Slide one. BioThread: Wearable Diagnostics for the Underserved. She had been working on it for three years. She could recite every slide in her sleep, in the dark, upside down, under pressure. She was ready. She was absolutely not ready. · · · The Caldwell Accelerator ran its intake day like a theatre production — all controlled tension and choreographed timing. Twelve founders. Twelve pitches. A panel of four investors who had heard every idea and funded perhaps one in fifty. Nora had studied them. The woman on the end, Priya Mehta, liked clean unit economics. The older gentleman beside her, Gerald Forsythe, wanted a moat. The two in the middle were, according to LinkedIn and three hours of Nora's Sunday night, Oliver Trent and James Ashford. She had not studied James Ashford enough. She knew he was the managing partner of Ashford Capital thirty-three, Oxford-educated, known for a bluntness in Q&A that made other founders pale. She had not, however, accounted for the fact that the man was there was no other word tall. He walked into the room with two minutes to spare, six feet of composed British restraint in a charcoal suit with no tie, and the sort of face that belonged on the cover of something serious, like an economics journal or a court summons. Dark hair pushed back from his forehead. A jaw that seemed architecturally intentional. He spoke briefly to Priya, tapped something on his phone, and sat without scanning the room for anyone interesting. Good, Nora told herself. Boring. Intimidating and boring. She turned back to her deck. "She had three years of data, two patents pending, and one body that refused to look the part. She had stopped apologising for the latter somewhere around year two." She was the fifth presenter. She watched the four before her with a clinical eye: two were strong, one was nervous, one was dreadful. Ashford took notes during all four. He did not smile. He asked questions in a clipped, unhurried accent that made each word feel load-bearing, and he cut through vague answers with the quiet efficiency of someone who had no time to waste on fog. When they called her name, Nora stood, smoothed her jade-green blazer over her hips a deliberate choice; she owned her body the way she owned her data, without apology and walked to the front of the room. "Nora Flynn. BioThread." She clicked to her first slide. "Eight hundred million people worldwide manage chronic illness with tools designed for hospitals, not for humans. We're changing that." She did not shake. That surprised her a little, every single time. She moved through the deck the way she moved through most things — efficiently, with the occasional detour into something unexpected. She cited three clinical studies. She explained the thread-based biosensor with a metaphor involving knitting that got an actual laugh from Gerald Forsythe. She laid out her go-to-market in West Africa first, then Southeast Asia — markets that other wearable companies had written off as too complex, too costly, not worth the translation. "Those markets," she said, "aren't difficult. They're underestimated. There's a difference." She clicked to her final slide. Thanked them. Waited. Priya asked about the supply chain. Nora answered. Gerald asked about regulatory clearance in Nigeria; Nora had numbers. Oliver Trent was halfway through a question about her Series A timeline when James Ashford interrupted politely, but with the finality of a door closing. "The thread substrate," he said, leaning forward slightly. "You're using a bio-reactive polymer composite, yes? I read the patent application." A pause. "Which cross-contamination protocol are you using in the manufacturing stage, and have you pressure-tested it against the humidity conditions in coastal West African climates?" The room went quiet in the specific way rooms go quiet when someone asks a question they expect to go unanswered. Nora looked at him directly for the first time. His eyes were grey. She noticed that only because she was looking for somewhere to look that wasn't his expression, which was neutral in a way that felt, somehow, like a dare. "Yes to the polymer composite," she said. "We use a triple-layer encapsulation barrier with silica desiccant integration reduces moisture ingress by eighty-three percent in field tests. We ran trials in Accra and Lagos over eighteen months. The degradation curve stays within acceptable diagnostic tolerance up to ninety percent relative humidity." She tilted her head, just slightly. "I assume that answers the question you were actually asking, which is whether I've been there." Something shifted in his face. Not a smile not quite. But the absolute blankness broke for just a moment, like a c***k in a frozen river, and Nora had the disorienting sensation that she had just passed a test she hadn't been told she was taking. "It does," James Ashford said. And wrote something down. · · · She told herself it meant nothing. Investors wrote things down that was what they were there to do. She packed up her laptop, accepted a glass of water from a passing assistant, and stood by the tall windows overlooking the Thames, letting the morning light press warmth into the side of her face and the last of the adrenaline work its way out of her system. She did not look for him in the room. She was almost certain of that. "Ms. Flynn." The voice came from just behind her left shoulder low, precise, English in the way that old buildings are English, as though it had been there long before she arrived. Nora turned slowly, because she refused to startle, and found James Ashford standing approximately two feet away, jacket buttoned, phone nowhere in sight for the first time all morning. He was, up close, aggressively tall. "I'd like to schedule a follow-up," he said. "My office. Thursday. I have questions that weren't appropriate for the group session." Nora held his gaze. "What kind of questions?" He reached into his breast pocket and held out a card cream-coloured, heavy stock, his name embossed in simple black type. When she took it, their fingers did not touch. She noticed only because some foolish, warm-blooded part of her had expected them to. "The kind," James Ashford said, already turning away, "that I only ask when I'm seriously considering writing a cheque." He was halfway across the room before Nora remembered to exhale , and then her phone buzzed in her pocket. She pulled it out. A message from an unknown number, sent forty seconds ago. It was a single line of text, and when she read it, the card in her hand suddenly felt less like an invitation and far more like a warning.